Quantum Biopharma Ltd. (CVE:QNT) Director Donal Carroll Purchases 500 Shares of Stock

Quantum Biopharma Ltd. (CVE:QNT – Get Free Report) Director Donal Carroll bought 500 shares of Quantum Biopharma stock in a transaction on Monday, July 14th. The stock was purchased at an average price of C$29.22 per share, with a total value of C$14,608.00. Quantum Biopharma Price Performance Analyst Ratings Changes Separately, Singular Research upgraded shares […]

Leave a Reply

Your email address will not be published.

Previous post Keudell Morrison Wealth Management Increases Holdings in NVIDIA Corporation (NASDAQ:NVDA)
Next post AIFG Consultants Ltd. Buys 754 Shares of NVIDIA Corporation (NASDAQ:NVDA)